January 26, 2022 In a study funded by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an international survey to obtain information
January 25, 2022 Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related health and
January 25, 2022 Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies about Down syndrome-related health and
Impaired immune function is a clear and growing threat to the health and well-being of people with Down syndrome (DS).
Findings from a recent study of the largest documented cohort of individuals with Down syndrome (DS) in the United States
Findings from a recent study describing prevalence of common disease conditions in the largest documented cohort of individuals with Down
The work shows the cellular and humoral responses to SARS-CoV-2 vaccination of 36 individuals with Down syndrome (DS) after one
Impaired immune function is a clear and growing threat to the health and well-being of people with Down syndrome (DS).
January 12, 2022 During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development of new drugs
January 12, 2022 During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that the development of new drugs
